Related references
Note: Only part of the references are listed.Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital
A. C. Budd et al.
THROMBOSIS RESEARCH (2021)
Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis
Soravis Osataphan et al.
BLOOD ADVANCES (2021)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer (vol 5, pg 927, 2021)
G. H. Lyman et al.
BLOOD ADVANCES (2021)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial
Walter Ageno et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States
Ang Li et al.
CANCER (2020)
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
A. J. Munoz Martin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Prevention of Venous Thromboembolism in 2020 and Beyond
Matthew Nicholson et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial
Jeffrey Zwicker et al.
BLOOD ADVANCES (2020)
Inpatient prophylaxis in cancer patients: where is the evidence?
Rushad Patell et al.
THROMBOSIS RESEARCH (2020)
Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis
Floris T. M. Bosch et al.
BLOOD ADVANCES (2020)
Cancer-Associated Thrombosis: A Two-Way Street
Bal Krishan Sharma et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience
R. Figueroa et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Treatment and Prevention of Cancer-Associated Thrombosis in Frail Patients: Tailored Management
Florian Scotte et al.
CANCERS (2019)
Cancer-associated thrombosis: the when, how and why
Caio J. Fernandes et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer
A. Parker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Norbaini Binti Abdol Razak et al.
CANCERS (2018)
Cancer and Venous Thromboembolic Disease: A Review
Eoin Donnellan et al.
ONCOLOGIST (2017)
Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool
Rushad Patell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Cancer-associated thrombosis
Harry E. Fuentes et al.
DM DISEASE-A-MONTH (2016)
Guidance for the prevention and treatment of cancer-associated venous thromboembolism
Alok A. Khorana et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Guideline on aspects of cancer-related venous thrombosis
Henry G. Watson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis
J. C. Easaw et al.
CURRENT ONCOLOGY (2015)
Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
Marc Carrier et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Clinical guide SEOM on venous thromboembolism in cancer patients
A. J. Munoz Martin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines
Soo-Mee Bang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain
Antonio Gomez-Outes et al.
PHARMACOECONOMICS (2014)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Patient Education Program for Venous Thromboembolism Prevention in Hospitalized Patients
Gregory Piazza et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Susan R. Kahn et al.
CHEST (2012)
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
M. Mandala et al.
ANNALS OF ONCOLOGY (2011)
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
Samuel Z. Goldhaber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Venous thromboembolism and cancer: a systematic review
Celso Arrais Rodrigues et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
Alexander T. Cohen et al.
LANCET (2008)
Venous thromboembolism in the outpatient setting
Frederick A. Spencer et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)
M. Mandala et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz et al.
CIRCULATION (2004)
Share Paper
